Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 201,500
+20,500 (11.33%)
Last updated: Jan 2, 2026, 2:45 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 39.6 trillion as of December 31, 2025. Its market cap has increased by 4.06% in one year.
Market Cap
39.60T
Enterprise Value
41.68T
Revenue
3.90T
Ranking
n/a
PE Ratio
54.63
Stock Price
201,500.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 39.60T, an increase of 38,051.29%. That is a compound annual growth rate of 40.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.46T |
| ALTEOGEN | 24.04T |
| ABL Bio | 11.03T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.39T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.32T |
| Peptron | 5.92T |